PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND THERAPEUTIC PHARMACEUTIC COMPOSITION COMPRISING SAME
申请人:Korea Institute of Science and Technology
公开号:EP4105213A1
公开(公告)日:2022-12-21
The present invention relates to a pyrido[[3,4-d]pyrimidine derivative compound showing excellent antiproliferative efficacy against cancer cells, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, a production method therefor, a pharmaceutical composition for preventing, alleviating, or treating cancer metastasis and proliferative diseases containing the same as an active ingredient, and an anticancer composition for cancer cells. The compound exhibits excellent inhibitory activity and antiproliferative efficacy against cancer cells, and thus the compound is useful not only for inhibiting cancer cells, but also for preventing cancer metastasis and proliferative diseases or for treating cancer.
本发明涉及一种吡啶并[[3,4-d]嘧啶衍生物化合物,其对癌细胞具有出色的抗增殖功效,以及其药学上可接受的盐、水合物或立体异构体、其生产方法、以该化合物为活性成分的预防、缓解或治疗癌转移和增生性疾病的药物组合物,以及用于癌细胞的抗癌组合物。该化合物表现出优异的抑制活性和抗增殖功效,因此该化合物不仅有助于抑制癌细胞,还可用于预防癌转移和增生性疾病或治疗癌症。